A psychedelic medicine biotech company, Mind Medicine Inc. (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), released full-year 2020 financial results Tuesday.
MindMed posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020.
Its total assets at the end of the reporting period were $85.6 million, counting $80.1 million in cash.
The company used $24.2 million of net cash in operating activities in 2020.
Its cash …
